485 related articles for article (PubMed ID: 31672564)
1. Deprescribing as a Clinical Improvement Focus.
Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
[TBL] [Abstract][Full Text] [Related]
2. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
3. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
[TBL] [Abstract][Full Text] [Related]
4. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
5. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials.
Dills H; Shah K; Messinger-Rapport B; Bradford K; Syed Q
J Am Med Dir Assoc; 2018 Nov; 19(11):923-935.e2. PubMed ID: 30108032
[TBL] [Abstract][Full Text] [Related]
7. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
[TBL] [Abstract][Full Text] [Related]
8. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
9. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
10. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
11. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
12. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing deprescribing habits among geriatricians.
Ní Chróinín D; Ní Chróinín C; Beveridge A
Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients.
Duncan I; Maxwell TL; Huynh N; Todd M
Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276
[TBL] [Abstract][Full Text] [Related]
15. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of a pilot pharmacist-led hospice deprescribing program initiative.
Le V; Patel N; Nguyen Q; Woldu H; Nguyen L; Lee A; Deguzman L; Krishnaswami A
J Am Geriatr Soc; 2021 May; 69(5):1370-1376. PubMed ID: 33772752
[TBL] [Abstract][Full Text] [Related]
17. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
[TBL] [Abstract][Full Text] [Related]
18. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist-driven deprescribing initiative in primary care.
Rea E; Portman D; Ioannou K; Lumley B
J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
